{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T21:43:38Z","timestamp":1725572618919},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.ejphar.2007.03.048","type":"journal-article","created":{"date-parts":[[2007,4,7]],"date-time":"2007-04-07T11:16:30Z","timestamp":1175944590000},"page":"67-76","source":"Crossref","is-referenced-by-count":6,"title":["Clinical efficacy of buprenorphine to minimize distress in MRL\/lpr mice"],"prefix":"10.1016","volume":"567","author":[{"given":"Julie","family":"Swenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selen","family":"Olgun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Radjavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taranjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.03.048_bib1","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2007.03.048_bib2","first-page":"157","article-title":"Haematological changes in buprenorphine-treated mice","volume":"45","author":"Banerjee","year":"1997","journal-title":"Folia Biol. (Krakow)"},{"key":"10.1016\/j.ejphar.2007.03.048_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.11.052","article-title":"Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain","volume":"507","author":"Christoph","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib4","first-page":"58","article-title":"Analgesic efficacy of acetaminophen and buprenorphine administered in the drinking water of rats","volume":"36","author":"Cooper","year":"1997","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"10.1016\/j.ejphar.2007.03.048_bib5","first-page":"23","article-title":"Buprenorphine: new pharmacological aspects","volume":"3\u20138","author":"Cowan","year":"2003","journal-title":"Int. J. Clin. Pract., Suppl."},{"key":"10.1016\/j.ejphar.2007.03.048_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1521-6616(03)00177-3","article-title":"No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters","volume":"109","author":"D'Elia","year":"2003","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib7","first-page":"628","article-title":"Buprenorphine given after surgery does not alter renal ischemia\/reperfusion injury","volume":"50","author":"Deng","year":"2000","journal-title":"Comp. Med."},{"key":"10.1016\/j.ejphar.2007.03.048_bib8","first-page":"8","article-title":"The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice","volume":"39","author":"Gades","year":"2000","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"10.1016\/j.ejphar.2007.03.048_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejphar.2007.03.048_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s005400170004","article-title":"Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine","volume":"15","author":"Gringauz","year":"2001","journal-title":"J. Anesth."},{"key":"10.1016\/j.ejphar.2007.03.048_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2460\/javma.2003.222.1505","article-title":"Critical anthropomorphic evaluation and treatment of postoperative pain in rats and mice","volume":"222","author":"Gross","year":"2003","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.ejphar.2007.03.048_bib12","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.npp.1300463","article-title":"Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice","volume":"29","author":"Ide","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.03.048_bib13","series-title":"Recognition and Alleviation of Pain and Distress in Laboratory Animals","author":"Institute of Laboratory Animal Resources (U.S.)","year":"1992"},{"key":"10.1016\/j.ejphar.2007.03.048_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-4362.1996.tb03021.x","article-title":"Cutaneous manifestations of systemic lupus erythematosus: study from Lahore, Pakistan","volume":"35","author":"Kapadia","year":"1996","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejpain.2005.02.002","article-title":"Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice","volume":"9","author":"Kogel","year":"2005","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2007.03.048_bib16","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1645\/GE-732R.1","article-title":"Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice","volume":"91","author":"Lindsay","year":"2005","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0306-3623(91)90452-C","article-title":"Buprenorphine: bell-shaped dose\u2013response curve for its antagonist effects","volume":"22","author":"Lizasoain","year":"1991","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pain.2004.04.020","article-title":"Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses","volume":"110","author":"Martucci","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2007.03.048_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/jpet.103.048835","article-title":"Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse","volume":"306","author":"Mizoguchi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.03.048_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1521-6616(03)00035-4","article-title":"Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL\/lpr mice","volume":"107","author":"Molano","year":"2003","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2005.12.035","article-title":"Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice","volume":"532","author":"Mori","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2249.2004.02428.x","article-title":"High expression of interleukin-1beta in the corneal epithelium of MRL\/lpr mice is under the control of their genetic background","volume":"136","author":"Okamoto","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-8993(96)01069-4","article-title":"Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia","volume":"744","author":"Pick","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.03.048_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1385\/IR:25:2:143","article-title":"Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL\/lpr mice","volume":"25","author":"Reilly","year":"2002","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ejphar.2007.03.048_bib25","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.4049\/jimmunol.164.3.1498","article-title":"Inhibition of mesangial cell nitric oxide in MRL\/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists","volume":"164","author":"Reilly","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1523-1755.2002.00230.x","article-title":"Modulation of renal disease in MRL\/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase","volume":"61","author":"Reilly","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2007.03.048_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/eji.200535245","article-title":"Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL\/lpr mice","author":"Reilly","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00008877-200411000-00002","article-title":"Behaviour-based assessment of the duration of laparotomy-induced abdominal pain and the analgesic effects of carprofen and buprenorphine in rats","volume":"15","author":"Roughan","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib29","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.4049\/jimmunol.166.10.6444","article-title":"Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL\/lpr mice","volume":"166","author":"Sekine","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib30","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.4049\/jimmunol.169.5.2461","article-title":"The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses l-selectin and high levels of CCR7","volume":"169","author":"Szanya","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib31","first-page":"319","article-title":"Body condition scoring: a rapid and accurate method for assessing health status in mice","volume":"49","author":"Ullman-Cullere","year":"1999","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.ejphar.2007.03.048_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2003.08.007","article-title":"Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system","volume":"477","author":"Umeuchi","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2005.06.019","article-title":"Spontaneous scratching behavior in MRL\/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride","volume":"518","author":"Umeuchi","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.03.048_bib34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1258\/002367797780596211","article-title":"Analgesics in mice used in cancer research: reduction of discomfort?","volume":"31","author":"van Loo","year":"1997","journal-title":"Lab. Anim."},{"key":"10.1016\/j.ejphar.2007.03.048_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907003573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907003573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T10:55:19Z","timestamp":1546944919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907003573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0014299907003573"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.03.048","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}